In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Kidney diseases, particularly chronic kidney disease (CKD), fundamentally impair the kidneys' ability to eliminate waste ...

New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

One 26-year-old mother of six in Arkansas is reaching out for the public’s help as she battles stage 5 kidney failure and ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Approximately 1 in 11 patients with kidney failure requiring replacement therapy have inherited kidney diseases or congenital anomalies of the kidney and urinary tract. Genetic testing is warranted to ...

The number of people living with CKD worldwide rose from 378 million in 1990 to 788 million in 2023. Here is what is ...

Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Type 2 diabetes medication Ozempic has been linked to a host of potential benefits outside of blood sugar management, including weight loss and helping to break addictions. Ozempic side effects tend ...